The fifth taste — and why it matters for satiety
Humans have five basic tastes. Four of them — sweet, salty, sour, bitter — have been described for centuries. The fifth, umami, was identified by Japanese chemist Kikunae Ikeda in 1908 and takes its name from the Japanese words for "delicious" and "taste." Ikeda was trying to identify what made dashi broth so deeply satisfying in a way that the other four tastes alone could not explain. The answer was glutamate — a freely occurring amino acid that activates its own specific taste receptors (T1R1/T1R3 heterodimers on taste cells) and produces a quality of savouriness, depth, and fullness that no single other taste replicates.
Umami is relevant to satiety for a specific reason. Of all five tastes, umami has the strongest connection to protein detection — and protein is the most satiating macronutrient. When the taste system detects glutamate, it signals to the brain: protein incoming. The cephalic phase response fires — anticipatory insulin release, digestive enzyme production, gastric acid secretion — and the satiety circuitry primes itself to respond to the protein load it expects. Umami-rich foods — meat, aged cheese, mushrooms, anchovies, soy, fermented foods — tend to produce stronger and earlier satiety signals than foods of equivalent caloric density that lack glutamate.
Receptor: TRPM5 / T1R2+T1R3
Sweet
Signals carbohydrate energy. Drives dopamine release in reward pathways. Easily overridden by palatability — one of the most exploited taste channels in processed food design.
Receptor: ENaC channels
Salty
Signals mineral content and electrolyte balance. Enhances all other tastes by suppressing bitter and amplifying sweet and fat perception. The reason salted butter tastes better than unsalted on identical bread.
Receptor: PKD2L1 / PKD1L3
Sour
Signals acidity and fermentation. Fermented foods — sourdough, kefir, aged cheese — trigger sour detection alongside umami, producing a complexity that is deeply satisfying and not easily replicated by simple or processed foods.
Receptor: T2R family (25 types)
Bitter
Signals potential toxins. Has 25 different receptor types — far more than any other taste — because bitter substances in nature were most likely to be harmful. Dark chocolate's bitterness activates these receptors, which is part of why it pairs so effectively with sweet and salt.
Receptor: T1R1+T1R3 heterodimer
Umami
Signals amino acids and protein. The most satiety-relevant taste. Glutamate from aged cheese, cured meat, mushrooms, anchovies, miso, soy. Produces the "coating" quality that makes food feel satisfying rather than just pleasant. Strongly activates cephalic phase satiety response.
What actually happens when you eat salted butter on sourdough
The combination you reach for — salted butter on sourdough, dark chocolate with sea salt and almonds, a really good charcuterie board — is not random palatability. It is a convergence of multiple sensory inputs that together produce a neurological response qualitatively different from any single element. Understanding each layer explains why stopping is genuinely difficult, and why certain combinations are almost impossible to eat in small quantities.
The neurobiological event of eating salted butter on sourdough
What happens in the brain and gut from first bite to "I probably should stop"
01
Visual and olfactory cues trigger the cephalic phase response. Before the food reaches your mouth, the sight and smell activate anticipatory insulin release, gastric acid production, and digestive enzyme secretion. The brain is already preparing for the nutrient load it expects based on sensory prediction.
02
Fat contact with taste cell receptors (CD36) triggers endocannabinoid release. Fat — specifically the butterfat — activates CD36 receptors on taste cells, stimulating the release of anandamide and 2-AG (the body's own endocannabinoids) in the gut. These signal back to the brain's reward circuitry via the vagus nerve, amplifying pleasure and creating the "this is really good, have more" signal.
03
Salt suppresses bitter, amplifies fat and sweet perception. The salt in the butter suppresses the slight bitterness of the sourdough crust and simultaneously enhances fat taste perception. This is why salted butter tastes disproportionately better than unsalted — not just saltier, but genuinely more complex and satisfying.
04
Sourdough fermentation produces organic acids that slow starch digestion. Properly fermented sourdough has a lower glycaemic response than standard bread — acetic and lactic acid from fermentation slow amylase activity. This reduces the glucose spike and avoids the reactive hypoglycaemia that makes you hungry again an hour after eating standard bread.
05
GLP-1 begins to release from L-cells in the small intestine. As fat and protein reach the intestinal wall, L-cells release GLP-1 — glucagon-like peptide-1 — which signals satiety to the brain via the vagus nerve and slows gastric emptying. This signal takes 15–20 minutes to reach the brain. If you're eating quickly, you've already had two more slices before it arrives.
06
The dopamine reward response has already evaluated this positively and wants repetition. The combined fat-salt-fermented-carbohydrate experience has activated the mesolimbic dopamine system — the same system involved in all reward-seeking behaviour. The evaluation was: very good. The instruction is: do it again. This signal is immediate. The satiety signal is delayed. The brain resolves the conflict in favour of the immediate signal unless the satiety signal is strong enough to override it.
The bliss point — and how it's engineered against you
The bliss point
The precise salt/fat/sugar combination that maximises palatability — and why it's not accidental
The "bliss point" was a term coined by market research psychologist Howard Moskowitz in the 1970s — the precise combination of salt, fat, and sugar that produces maximum palatability without tipping into "too much." Moskowitz was working for food manufacturers. The concept was applied systematically to reformulate processed foods to hit the exact sensory sweet spot that maximises consumption while minimising the satiety signal that would tell you to stop. This is not a conspiracy theory — it is documented food industry practice, described in detail by journalist Michael Moss in his book Salt Sugar Fat and confirmed by the internal research of companies including Frito-Lay, Coca-Cola, and Kraft. The engineered palatability of ultra-processed food is not the same phenomenon as the natural palatability of butter on sourdough, even though both feel similar in the eating. The difference is that whole food palatability — fat combined with fermentation and salt in natural proportions — comes packaged with fibre, fermentation byproducts, and a nutrient matrix that supports GLP-1 release and genuine satiety. Engineered palatability hits the same sensory receptors while providing minimal nutritional signal and reduced satiety response. This is why you can eat an entire packet of crisps and still want more — and why the same caloric quantity of cheese and sourdough tends to feel satisfying.
GLP-1 — the satiety signal that Ozempic amplifies
Glucagon-like peptide-1 (GLP-1) is a hormone released from L-cells in the small intestine and colon in response to nutrient contact with the intestinal wall. It does several things simultaneously: signals satiety to the hypothalamus via the vagus nerve, slows gastric emptying (food sits in the stomach longer, producing physical fullness for longer), stimulates insulin release in response to glucose, suppresses glucagon (reducing hepatic glucose output), and may reduce food reward signals in the brain's mesolimbic system.
GLP-1 agonist medications — Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide) — work by amplifying a signal the body produces naturally but often too weakly to override the palatability drive. The weight loss they produce is not primarily through suppressing hunger — it is through finally giving the satiety system enough signal strength to compete with the reward system. Which raises the question: why do some people produce adequate GLP-1 responses to meals and regulate appetite normally, while others don't?
High gut microbiome diversity with adequate Akkermansia muciniphila
Sufficient dietary fibre — fermentable fibre producing SCFAs that stimulate L-cells
Protein at the start of meals — strongest GLP-1 stimulus of all macronutrients
Slow eating — 20+ minutes allows GLP-1 signal to reach brain before overconsumption
Adequate sleep — sleep deprivation reduces GLP-1 sensitivity
Low systemic inflammation — inflammatory cytokines impair GLP-1 receptor signalling
Low gut microbiome diversity — depleted Akkermansia reduces L-cell stimulation
Low fibre intake — insufficient SCFA production, reduced L-cell activation
Carbohydrate-first meals — weaker GLP-1 stimulus than protein
Fast eating — food reaches satiety centre 20 minutes after it should have
Chronic sleep deprivation — reduces GLP-1 sensitivity and amplifies ghrelin
Chronic low-grade inflammation — impairs GLP-1 receptor signalling at target tissues
The Akkermansia connection — your gut microbiome and your satiety signal
Akkermansia muciniphila is a mucin-degrading bacterium that lives in the mucus layer lining the intestinal wall. It is one of the most studied bacteria in the emerging field of gut-weight relationships, and for good reason. Akkermansia abundance is associated with healthier metabolic profiles, better insulin sensitivity, lower inflammatory markers, and — critically — enhanced GLP-1 secretion.
The mechanism appears to involve Akkermansia's role in maintaining gut barrier integrity and its production of specific short-chain fatty acids that directly stimulate L-cells to release GLP-1. Studies in both animal models and humans have found that Akkermansia-depleted gut microbiomes produce weaker GLP-1 responses to identical meals. The implication: two people eating the same food at the same pace may have significantly different satiety signal strength based on differences in their gut microbiome — specifically in Akkermansia abundance.
Akkermansia is now measurable on the GI-MAP stool analysis. It is depleted by antibiotics, proton pump inhibitors, a low-fibre diet, and chronic stress. It is supported by prebiotic fibre (particularly inulin and polyphenols), pomegranate extract, and — interestingly — time-restricted eating, which allows the mucus layer to be maintained rather than constantly degraded by digestive activity.
The testing argument for satiety
If someone has struggled with appetite regulation, portion control, or weight management despite genuine effort, the question worth asking before recommending willpower or caloric restriction is: what does their gut microbiome look like? Is Akkermansia present at adequate levels? Is their inflammatory profile suppressing GLP-1 receptor sensitivity? Is their insulin resistance creating a pattern where blood sugar instability drives eating independent of hunger? These are testable questions — not hypothetical ones. The GI-MAP, Metabolomix+ OAT, and blood chemistry together provide a picture of the satiety-relevant biology that no dietary advice alone addresses.
Umami as a satiety tool — the foods that make the signal stronger
High-Umami Foods
The flavour that signals protein, drives cephalic phase response, and supports satiety
Aged Parmesan
Anchovies
Mushrooms (esp. dried)
Miso paste
Soy sauce (naturally brewed)
Bone broth
Tomato (ripe, concentrated)
Fermented fish sauce
Beef / lamb (particularly slow-cooked)
Seaweed (kombu)
Nutritional yeast
Liver (especially chicken)
The practical application: building umami into meals — not as a flavour trick but as a satiety strategy — tends to produce earlier and more persistent satiety signals. A bowl of ramen with bone broth, mushrooms, and a soft-boiled egg produces a qualitatively different satiety response than the same caloric content from a plain chicken breast and white rice. The umami matrix in the broth — glutamate, inosinate from the chicken, guanylate from the mushrooms — creates a synergistic flavour effect that is more than the sum of its parts and a stronger satiety signal than any single component alone.
Mouthfeel, texture, and the satiety signal you can't fake
Texture affects satiety through a mechanism most nutritional science ignores: oral processing time. The longer food requires chewing and processing in the mouth, the stronger and earlier the cephalic phase satiety response. This is one reason why liquid calories — smoothies, juices, protein shakes — tend to produce weaker satiety than the same calories consumed as whole food. The oral processing step is largely bypassed, and with it the sensory satiety signal that chewing generates.
Fat texture specifically — the creaminess of butter, double cream, avocado, marbled meat — activates CD36 fat taste receptors in ways that fat in other forms does not. A smoothie containing avocado produces a different receptor activation pattern from eating the same avocado whole, because the physical texture and the rate of release of fatty acids differ. This is not a small effect — it contributes meaningfully to the satiety differential between whole foods and processed versions of the same ingredients.
The dark chocolate/sea salt/almond combination you mentioned is a master class in multisensory palatability: the snap of the chocolate (auditory and tactile feedback that signals quality and triggers anticipation), the initial bitterness resolved by the salt, the sustained fat release as the chocolate melts, the textural contrast of the almond, the umami-adjacent quality of good dark chocolate at high cacao percentages, and the slight saltiness that enhances every other flavour channel simultaneously. It is genuinely difficult to eat in small quantities — and understanding why is the beginning of being able to.
The person who can stop at one piece of 85% dark chocolate with sea salt has either a very well-functioning satiety system, an exceptionally strong executive function capacity, or they're not actually that hungry. Most people in most situations will struggle. This is not a character flaw — it is a feature of a system that evolved to maximise caloric intake when caloric-dense food was available, encountering a food that exploits that system more efficiently than evolution anticipated.
What you can actually do — the intervention picture
Intervention 01
Protein first at every meal
Protein is the strongest GLP-1 stimulus of all macronutrients. Starting the meal with protein — before carbohydrates — amplifies and advances the satiety signal. 25–30g protein at the first meal sets the appetite tone for the day.
Mechanism: L-cell GLP-1 release stimulated preferentially by amino acids and protein hydrolysates
Intervention 02
Eat slowly — 20 minute minimum
The GLP-1 signal takes 15–20 minutes to travel from gut to brain. Eating in under 15 minutes means consuming well past satiety before the signal arrives. Putting down cutlery between bites, chewing thoroughly, and extending meal duration to at least 20 minutes closes the gap.
Mechanism: vagal GLP-1 signalling delay — the signal exists, it just needs time to arrive
Intervention 03
Fermentable fibre daily
Inulin (onions, garlic, leeks, asparagus, chicory), resistant starch (cooled cooked potato, green banana, oats), and pectin (apples, carrots) feed the bacteria that produce the SCFAs that stimulate L-cells to release GLP-1. Not all fibre is equal — fermentable fibre is the relevant fraction.
Mechanism: butyrate and propionate from SCFA-producing bacteria stimulate colonic L-cell GLP-1 secretion
Intervention 04
Support Akkermansia
Pomegranate extract, cranberry polyphenols, and time-restricted eating (12–14 hour overnight fast) all support Akkermansia muciniphila abundance. Avoid unnecessary antibiotics and PPI medication where possible — both deplete Akkermansia significantly.
Mechanism: Akkermansia maintains mucus layer integrity and directly stimulates L-cell GLP-1 release
Intervention 05
Sleep 7–9 hours consistently
Sleep deprivation increases ghrelin (hunger signal), reduces GLP-1 sensitivity, and impairs executive function — the last line of defence against eating past satiety. A single night of poor sleep measurably increases next-day caloric intake in controlled studies.
Mechanism: ghrelin/leptin dysregulation + reduced GLP-1 receptor sensitivity + impaired prefrontal inhibition
Intervention 06
Reduce systemic inflammation
Chronic low-grade inflammation — elevated hsCRP, IL-6, TNF-alpha — impairs GLP-1 receptor signalling at target tissues. The gut-health interventions above reduce inflammation. So does omega-3 supplementation, sleep, exercise, and reducing reactive foods identified on food sensitivity testing.
Mechanism: inflammatory cytokines downregulate GLP-1 receptor expression and impair post-receptor signalling cascades
Intervention 07
Build umami into meals deliberately
Anchovy paste, miso, parmesan, mushrooms, bone broth — building umami-rich ingredients into meals produces stronger and earlier satiety signals than the same caloric content without glutamate. This is not a trick — it is working with the taste-satiety system that already exists.
Mechanism: glutamate activates T1R1/T1R3 receptors, driving cephalic phase satiety response and protein-detection circuits
Intervention 08
Distinguish real from engineered palatability
Whole food palatability — butter on sourdough, dark chocolate, good cheese — comes with fibre, fermentation byproducts, and nutrient density that support satiety biology. Engineered ultra-processed palatability hits the same receptors without the satiety-supporting matrix. They feel similar going in. The body's response over the following hours is different.
Mechanism: food matrix determines post-absorptive signalling — identical sensory experience, different metabolic response
The honest position on appetite and weight
None of this makes appetite regulation easy. The palatability drive in the presence of caloric-dense food is powerful, immediate, and evolutionarily ancient. The satiety signal is slower, weaker in many people, and easily overridden by stress, sleep deprivation, social context, and habit. The interventions above improve the biology. They do not eliminate the challenge.
What they do is shift the playing field. Someone with a diverse gut microbiome, adequate Akkermansia, low systemic inflammation, good sleep, and a protein-first eating pattern has a meaningfully stronger satiety system than someone without those foundations — and therefore needs to rely less on willpower to achieve the same outcome. This is the functional medicine argument applied to appetite: address the biology first, then the behavioural strategy has something to work with.
The GLP-1 medications work because they pharmacologically provide the signal strength the body cannot generate on its own. Building the biological foundation for GLP-1 production — gut microbiome diversity, fibre intake, sleep, inflammation reduction — is the food-first version of the same intervention. Less dramatic, slower, but building something durable rather than dependent.
Know what your satiety biology looks like
Akkermansia status, inflammatory markers, insulin resistance pattern, and gut barrier integrity — all measurable. If appetite regulation has been a persistent challenge despite genuine effort, the question worth answering is whether the biology is supporting you or working against you.
Book a conversation →
Related reading